Monica Mehta, MD
Neuromusculoskeletal Medicine, Sports Medicine · Jersey City, NJNPI 1427099985
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 14 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by Forte Bio-pharma LLC at 23.7% of the total. Reporting peaked in 2023 at $83 and has fallen 58.7% since, to $34 in 2025.
Across 14 payments — averaging $19.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Forte Bio-pharma LLC$66
- Medtronic$51
- Boston Scientific$50
- Johnson & Johnson$40
- AbbVie$29
- IBSA Pharma Inc.$29
- plus $14 from 1 others
What the payments were for
- Food & beverage$279100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Forte Bio-pharma LLC | 4 | $66 |
| Medtronic | 1 | $51 |
| Boston Scientific | 2 | $50 |
| Johnson & Johnson | 2 | $40 |
| AbbVie | 2 | $29 |
| IBSA Pharma Inc. | 2 | $29 |
| Protega Pharmaceutials Inc | 1 | $14 |
How this compares
Too few neuromusculoskeletal medicine, sports medicine providers in New Jerseyto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 51 | $2,170 |
| Oxycodone Hcl | 122 | $2,134 |
| Lidocaine | 16 | $1,652 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 71 | $1,082 |
| Tizanidine Hcl | 139 | $962 |
| Gabapentin | 96 | $784 |
| Meloxicam | 99 | $409 |
| Methylprednisolone | 29 | $258 |
| Cyclobenzaprine Hcl | 39 | $182 |
| Alprazolam | 17 | $77 |
Paid to pharmacies, not to this prescriber.
Other neuromusculoskeletal medicine, sports medicine in Jersey City
- Magdy ElamirJersey City$16
- Sammy MasriParamus$5K
- Richard NachwalterMorristown$1K
- James GentileWhitehouse Station$266
- Carl GiordanoMorristown$246
- Philip PaparoneGalloway$91
- Martin DiamondWestfield$67
- James KimCliffside Park$50
- Walter BakunMorris Plains$19
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.